ArticleOpen heart
Comparative early outcomes of tricuspid Valve repair versus replacement for secondary tricuspid regurgitation.
Article in Open heart. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Isolated surgical tricuspid repair versus replacement: meta-analysis of 15 069 patients.Open heart · 2020Pooled it
- Three decades evolution of the lifetime management approach to tricuspid valve disease: a multidisciplinary European perspective from a high-volume heart valve center.Annals of cardiothoracic surgery · 2026Article
- Survival and Risk Profile of Patients With Significant Tricuspid Regurgitation by Etiology.Journal of the American Heart Association · 2026Article
- Incidence and Risk Factors for Permanent Pacemaker Implantation After Tricuspid Valve Repair.Annals of thoracic surgery short reports · 2025Article
- [MSB-29] Comparative Analysis of Mechanical and Bioprosthetic Valves in Tricuspid Valve Replacement.Turk gogus kalp damar cerrahisi dergisi · 2024Article
- Tricuspid Edge-to-Edge Repair Versus Tricuspid Valve Replacement for Severe Tricuspid Regurgitation.Korean circulation journal · 2023Article
- We Found a Gem in Your Heart: Valvular Heart Disease and Infective Endocarditis Discovered.Cureus · 2023Article
- Tricuspid valve: Once disregarded, now acknowledged.International journal of cardiology. Congenital heart disease · 2022Review
- Contemporary review in the multi-modality imaging evaluation and management of tricuspid regurgitation.Cardiovascular diagnosis and therapy · 2021Review
- Isolated tricuspid valve surgery; long-term outcomes based on Tehran Heart Center data bank report.Journal of cardiothoracic surgery · 2021Article
- Determinants of Morbidity and Mortality Associated With Isolated Tricuspid Valve Surgery.Journal of the American Heart Association · 2021Article
- Minimally invasive tricuspid valve surgery and concomitant MAZE procedure with closure of LA appendage through an ASD.Clinical case reports · 2021Article
- Refining Severe Tricuspid Regurgitation Definition by Echocardiography with a New Outcomes-Based "Massive" Grade.Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography · 2020Article
- Late Outcomes of Valve Repair Versus Replacement in Isolated and Concomitant Tricuspid Valve Surgery: A Nationwide Cohort Study.Journal of the American Heart Association · 2020Article
- Tricuspid Valve Regurgitation: Current Understanding and Novel Treatment Options.Journal of the Society for Cardiovascular Angiography & InterventionsReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Comparative outcome data on tricuspid valve repair (TVr) versus tricuspid valve replacement (TVR) for severe secondary tricuspid regurgitation (TR) are limited. Methods: We used a national inpatient sample to assess in-hospital morbidity and mortality, length of stay and cost in patients with severe secondary TR undergoing isolated TVr versus TVR. Results: A total of 1364 patients (national estimate=6757) underwent isolated tricuspid valve surgery during the study period, of whom 569 (41.7%) had TVr and 795 (58.3%) had TVR. There was no difference in the prevalence of major morbidities between the two groups, except for liver disease and hepatic cirrhosis, which were more common in the TVR group. Before propensity matching, in-hospital mortality was similar between patients who underwent isolated TVr and TVR (8.1% vs 10.8%, p=0.093), but the incidence of postoperative morbidities differed: TVR was associated with higher rates of permanent pacemaker implantation and blood transfusion, while TVr was associated with more acute kidney injury. After rigorous propensity score matching, TVR was associated with significantly higher rates of in-hospital death (12% vs 6.9%, p=0.009) and permanent pacemaker implantation (33.7% vs 11.2%, p<0.001). Postoperative morbidities and length of stay, however, were not different between the two groups. Nonetheless, cost of hospitalisation was 16% higher in the TVr group. Conclusions: In patients undergoing isolated surgery for secondary TR, TVR is associated with higher in-hospital mortality and need for permanent pacemaker compared with TVr. Further studies are needed to understand the impact of the type of surgery on the short-term and long-term mortality in this complex undertreated population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.